Label-free reflectometric interference microchip biosensor based on nanoporous alumina for detection of circulating tumour cells

被引:107
作者
Kurneria, Tushar [1 ,4 ]
Kurkuri, Mahaveer D. [1 ,4 ]
Diener, Kerrilyn R. [2 ,3 ]
Parkinson, Luke [4 ]
Losic, Dusan [1 ,4 ]
机构
[1] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia
[2] Royal Adelaide Hosp, Hanson Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia
[3] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia
[4] Univ S Australia, Ian Work Res Inst, Mawson Lakes, SA 5095, Australia
基金
澳大利亚研究理事会;
关键词
Reflectometric interference spectroscopy; Optical biosensor; Label-free biosensor; Nanoporous alumina; Circulating tumour cells; QUARTZ-CRYSTAL MICROBALANCE; BREAST-CANCER CELLS; PERIPHERAL-BLOOD; POROUS SILICON; ARRAYS;
D O I
10.1016/j.bios.2012.02.038
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this report, a label-free reflectometric interference spectroscopy (RIfS) based microchip biosensor for the detection of circulating tumour cells (CTCs) is demonstrated. Highly ordered nanoporous anodic aluminium oxide (AAO) fabricated by electrochemical anodization of aluminium foil was used as the RIfS sensing platform. Biotinylated anti-EpCAM antibody that specifically binds to human cancer cells of epithelial origin such as pancreatic cancer cells (PANC-1) was covalently attached to the AAO surface through multiple surface functionalization steps. Whole blood or phosphate buffer saline spiked with low numbers of pancreatic cancer cells were successfully detected by specially designed microfluidic device incorporating an AAO RIfS sensor, without labour intensive fluorescence labelling and/or pre-enhancement process. Our results show that the developed device is capable of selectively detecting of cancer cells, within a concentrations range of 1000-100,000 cells/mL, with a detection limit of <1000 cells/mL, a response time of <5 min and sample volume of 50 mu L of. The presented RIfS method shows considerable promise for translation to a rapid and cost-effective point-of-care diagnostic device for the detection of CTCs in patients with metastatic cancer. Crown Copyright (c) 2012 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 42 条
[1]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[2]   A Label-Free Porous Alumina Interferometric Immunosensor [J].
Alvarez, Sara D. ;
Li, Chang-Peng ;
Chiang, Casey E. ;
Schuller, Ivan K. ;
Sailor, Michael J. .
ACS NANO, 2009, 3 (10) :3301-3307
[3]   The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors [J].
Alvarez, Sara D. ;
Derfus, Austin M. ;
Schwartz, Michael P. ;
Bhatia, Sangeeta N. ;
Sailor, Michael J. .
BIOMATERIALS, 2009, 30 (01) :26-34
[4]  
Baker MK, 2003, CLIN CANCER RES, V9, P4865
[5]  
Benez A, 1999, J CLIN LAB ANAL, V13, P229, DOI 10.1002/(SICI)1098-2825(1999)13:5<229::AID-JCLA7>3.3.CO
[6]  
2-P
[7]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[8]   An electrical biosensor for the detection of circulating tumor cells [J].
Chung, Yao-Kuang ;
Reboud, Julien ;
Lee, Kok Chuan ;
Lim, Hui Min ;
Lim, Pei Yi ;
Wang, Karen Yanping ;
Tang, Kum Cheong ;
Ji, HongMiao ;
Chen, Yu .
BIOSENSORS & BIOELECTRONICS, 2011, 26 (05) :2520-2526
[9]   Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer [J].
de Bono, Johann S. ;
Scher, Howard I. ;
Montgomery, R. Bruce ;
Parker, Christopher ;
Miller, M. Craig ;
Tissing, Henk ;
Doyle, Gerald V. ;
Terstappen, Leon W. W. M. ;
Pienta, Kenneth J. ;
Raghavan, Derek .
CLINICAL CANCER RESEARCH, 2008, 14 (19) :6302-6309
[10]   Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer [J].
Fan, Tina ;
Zhao, Qiang ;
Chen, John J. ;
Chen, Wen-Tien ;
Pearl, Michael L. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :185-191